Zai Lab Limited American Depositary Shares

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. BIOLASE, Inc. (NASDAQ: BIOL) On Jan. 29, Biolase reported full-year 2023 interim revenue of $48.9 million to $49.2 million, up 1% year-over-year compared to the consensus of $49.21 million. The company’s stock fell around 43% over the past five days ...

Related tickers: GILD, BIOL, ZLAB, REVB, CNSP.

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Monday. Shares of Archer-Daniels-Midland Company (NYSE: ADM) fell sharply in today’s pre-market trading after the company named Ismael Roig as Interim Chief Financial Officer. ADM also said it now expects an adjusted earnings per share of $6.90 for the fiscal year ended Dec. 2023. Archer-Daniels-Midland shares dipped 9.6% to $61.67 in pre-market trading. Here are some big stocks recording losses in today’s pre-market trading session. B. Riley Financial, Inc. (NASDAQ: RILY) shares tumbled 17.5% to $16.63 in pre-market trading. B. Riley Financial issued a statement in response ...

Related tickers: BIDU, CORT, ADM, CAN, DADA, RILY, ZLAB, HUYA, XPEV, ASTL.